Lisata Therapeutics (LSTA) Leases (2016 - 2025)
Historic Leases for Lisata Therapeutics (LSTA) over the last 8 years, with Q2 2025 value amounting to $47000.0.
- Lisata Therapeutics' Leases fell 7911.11% to $47000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $47000.0, marking a year-over-year decrease of 7911.11%. This contributed to the annual value of $138000.0 for FY2024, which is 5519.48% down from last year.
- According to the latest figures from Q2 2025, Lisata Therapeutics' Leases is $47000.0, which was down 7911.11% from $93000.0 recorded in Q1 2025.
- Lisata Therapeutics' Leases' 5-year high stood at $425000.0 during Q1 2023, with a 5-year trough of $47000.0 in Q2 2025.
- Its 3-year average for Leases is $242000.0, with a median of $246000.0 in 2024.
- In the last 5 years, Lisata Therapeutics' Leases tumbled by 3717.65% in 2024 and then crashed by 7911.11% in 2025.
- Lisata Therapeutics' Leases (Quarter) stood at $308000.0 in 2023, then tumbled by 55.19% to $138000.0 in 2024, then tumbled by 65.94% to $47000.0 in 2025.
- Its last three reported values are $47000.0 in Q2 2025, $93000.0 for Q1 2025, and $138000.0 during Q4 2024.